Meeting the challenge of neonatal hyperglycemia.
LBW and VLBW neonates have presented neonatal caregivers with a unique challenge to meet their nutritional and growth needs. Unfortunately, the neonate's immature physiologic function may lead to persistent glucose intolerance and a nonresponsiveness to endogenous insulin. The use of insulin infusions for the treatment of hyperglycemia may support normoglycemia and improve nutritional supplementation.
Amspacher
K A
KA
D001786:Blood Glucose / Q000378:metabolism; D002395:Catecholamines / Q000502:physiology; D005943:Gluconeogenesis; D005947:Glucose / Q000008:administration & dosage; D006801:Humans; D006943:Hyperglycemia / Q000453:epidemiology / Q000503:physiopathology* / Q000628:therapy; D015994:Incidence; D007223:Infant; D007263:Infusions, Parenteral; D007328:Insulin / Q000378:metabolism / Q000627:therapeutic use; D012307:Risk Factors
D001786:Blood Glucose; D002395:Catecholamines; D007328:Insulin; D005947:Glucose